ÂÜÀòÂÒÂ×

Daniel Wallerstorfer is an experienced leader in the biotechnology sector, currently serving as Chief Scientific Officer at 10X Health System and REVIV Global, and as CEO of both Darwin AG and Novogenia GmbH since founding the latter in 2009. Wallerstorfer has been at the helm of Innovogene since 2014. Educational credentials include a Bachelor of Science in Molecular Biology and a Doctor of Philosophy in Biotechnology, both obtained from The University of Manchester. Notably, Novogenia specializes in high-tech medical genetic laboratories and innovative technologies for personalizing supplements and cosmetics.